for treatment of lung disease
A research team at Yale has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.
Dr. Jack A. Elias, the Waldemar Von Zedtwitz Professor of Medicine, led the study, which examined how a molecule called TGF-beta causes apoptosis and abnormal scarring in the lungs. It was published in the Aug. 2 issue of the Journal of Experimental Medicine.
There are a variety of human diseases where normal tissue is replaced with scar tissue that doesn't function the same way as the original tissue, explains Elias. This results in dysfunction of the skin or other involved organs. People can develop fibrosis of the skin, which leads to conditions like sclerodoma, where the skin thickens. When this occurs in the lungs, it is called pulmonary fibrosis. In pulmonary fibrosis, the normally thin lung tissue is replaced with thick, coarse scar tissue that impairs the flow of oxygen into the blood and leads to a loss of lung function.
"Most people think that an excess of TGF-beta is the cause of the fibrosis, so we explored how TGF-beta actually does this," says Elias. He and a team that included Dr. Chun Geun Lee, assistant professor in internal medicine (pulmonary), created a transgenic mouse and targeted TGF-beta into the mouse lungs. This overexpression of TGF-beta caused pulmonary fibrosis to develop in the mouse. This unique experimental system allowed the research team to turn the gene on and off at will. They could time when the production of TGF-beta started and watch the sequence of events that occurred before pulmonary fibrosis developed.
"We discovered that TGF-beta causes the epithelial cells in the lung to die via apoptosis," says Elias. "Up until now, no one has really understood that this cell death comes before and is required for the development of pulmonary fibrosis. This is exciting because when biopsies of the lung from humans with pulmonary fibrosis are examined, fibrosis and apoptosis are observed simultaneously."
"We now know the mechanism involved in apoptosis in the lungs," Elias adds. "We could potentially treat fibrotic disorders in the lung by blocking apoptosis, and no one has ever done that before."
This latest finding by Elias and his team is part of a large body of work dedicated to research into lung diseases such as asthma and pulmonary fibrosis. The ultimate goal is development of new treatments for these disorders.
Other authors on the study include Soo Jung Cho, Min Jong Kang, Svetlana P. Cahpoval, Patty J. Lee, Paul W. Noble, Teshome Yehualaeshet, Bingeng Lu, Richard A. Flavell and Robert J. Homer of Yale; and Jeffrey Milbrandt of Washington University School of Medicine.
-- By Karen Peart
T H I S
W E E K ' SS T O R I E S
Yale fencer wins bronze and makes history at Olympics
ASSET-Dell deal provides discounts on home computers . . .
Levin addresses forum, honors Yale's first Chinese alumnus during trip
New M.B.A. program to train healthcare industry leaders
YALE LIBRARY NEWSExhibits celebrate 'the joys of reading' and library collections
Library's new food and drink policy aims to preserve materials
Foundations honored by University library . . .
Modernist icon is highlight of School of Architecture exhibit
Yale champions lend support to smoke-free campaign
In Memoriam: Shizuo Kakutani, noted mathematician and inventor
Visiting scholars will explore ethical issues
Study: Mutation makes cancer more aggressive in African-Americans
Air travel generally safe for cardiovascular patients, say scientists
Team's findings open new path for treatment of lung disease
Investigators get first look at atomic structure . . .
Scientists unravel how animals sense and distinguish odors
Studies show effects of transplanted bone marrow cellsResearchers find that donor's epithelial cells . . .
Early findings suggest that donor cells can regenerate . . .
Researchers discover how Hepatitis C enzyme unwinds RNA
Study reveals patterns of behavior associated with maintaining weight loss
Research underscores value of beta-blockers in treating heart patients
Report: Many older patients choose treatments . . .
Investigators' work offers insights into the biology of depression
Researchers win grants for research on women's health
Child Study Center receives grant to assess IICAPS
Yale physicians named 'top doctors' by colleagues in magazine poll
Maihle to chair Women in Cancer Research Council
'Chasing Rainbows' now on view in Yale Rep plaz
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home